P-0001 - Prueba Ana: Poster Titulo
P-007 - ABBREVIATED TREATMENT FOR EARLY-STAGE BREAST CANCER
P-011 - ACCELERATED PARTIAL BREAST IRRADIATION WITH MULTICATHETER BRACHYTHERAPY AFTER CONSERVING SURGERY
P-034 - BLADDER NECK PREDICTS URINARY TOXICITY IN ENDOMETRIAL CANCER TREATED BRACHYTHERAPY
P-036 - Brachytherapy for vaginal intraepithelial neoplasia VaINIII
P-037 - BRACHYTHERAPY IN INOPERABLE ENDOMETRIAL CANCER
P-038 - BRACHYTHERAPY WITH LEIPZIG APPLICATOR IN NON-MELANOMA SKIN CANCER: FIRST RESULTS
P-053 - CLINICAL, DOSIMETRIC AND RADIOBIOLOGICAL FACTORS FOR TOXICITY IN SKIN BT
P-054 - COMBINED RADIOTHERAPY, EXTERNAL PLUS BRACHYTHERAPY IN PROSTATE CANCER: LONG-TERM RESULTS
P-057 - COMPARISON OF DOSE CALCULATION ALGORITHMS IN BRACHYTHERAPY.
P-066 - CYTOREDUCTIVE THERAPY: THE OPTION PRIOR BRACHYTHERAPY FOR HIGH PROSTATE VOLUME?
P-094 - Electronic brachytherapy in non-melanoma skin cancer
P-109 - EXPERIENCE OF SALVAGE HIGH-DOSE-RATE PROSTATE BRACHYTHERAPY IN A SINGLE INSTUTITION
P-123 - FASE II HEMIGLANDULAR (FOCAL) BRACHYTHERAPY IN LOW RISK PROSTATE CANCER
P-127 - FIELD CANCERIZATION IN IMMUNOSUPPRESSED PATIENTS. EARLY RADIOTHERAPY A CHANGE NEEDED.
P-136 - G2-LATE VAGINAL COMPLICATIONS IN POSTOPERATIVE ENDOMETRIAL CANCER BRACHYTHERAPY: MULTIVARIATE ANALYSIS
P-137 - GEB (SEOR-SEFM) RECOMMENDATIONS FOR INTERSTITIAL-HDR IN GYNECOLOGIC MALIGNANCIES
P-138 - GENDER DIFFERENCES IN PROGNOSIS OF UVEAL MELANOMA
P-142 - HDR BRACHYTHERAPY AS MONOTHERAPY IN LOCALIZED PROSTATE CANCER: 2-YEARS ANALYSIS
P-143 - HDR-PROSTATIC BRACHYTHERAPY AS A RESCUE TREATMENT OPTION
P-148 - HIGH DOSE RATE BRACHYTHERAPY IN LUNG CANCER